References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:https://doi.org/10.3322/caac.21492
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA A Cancer J Clin. 2019;69(1):7–34. doi:https://doi.org/10.3322/caac.21551
- The Cancer Genome Atlas Research Network. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell. 2017; 32:185–203. doi:https://doi.org/10.1016/j.ccell.2017.07.007
- Bailey P, Australian Pancreatic Cancer Genome Initiative, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJC, Quinn MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47–52. doi:https://doi.org/10.1038/nature16965
- Daemen A, Peterson D, Sahu N, McCord R, Du X, Liu B, Kowanetz K, Hong R, Moffat J, Gao M, et al. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors. Proc Natl Acad Sci U S A. 2015;112(32):E4410–E4417. doi:https://doi.org/10.1073/pnas.1501605112
- Law HCH, Lagundžin D, Clement EJ, Qiao F, Wagner ZS, Krieger KL, Costanzo-Garvey D, Caffrey TC, Grem JL, DiMaio DJ, et al. The proteomic landscape of pancreatic ductal adenocarcinoma liver metastases identifies molecular subtypes and associations with clinical response. Clin Cancer Res. 2020;26(5):1065–76. doi:https://doi.org/10.1158/1078-0432.CCR-19-1496
- Puleo F, Nicolle R, Blum Y, Cros J, Marisa L, Demetter P, Quertinmont E, Svrcek M, Elarouci N, Iovanna J, et al. Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features. Gastroenterology. 2018;155(6):1999–2013. doi:https://doi.org/10.1053/j.gastro.2018.08.033
- Hu ZI, Shia J, Stadler ZK, Varghese AM, Capanu M, Salo-Mullen E, Lowery MA, Diaz LA Jr, Mandelker D, Yu KH, Zervoudakis A, et al. Evaluating mismatch repair deficiency in pancreatic adenocarcinoma: challenges and recommendations. Clin Cancer Res. 2018;24(6):1326–36. doi:https://doi.org/10.1158/1078-0432.CCR-17-3099
- Tsai HJ, Chang JS. Environmental risk factors of pancreatic cancer. JCM. 2019;8(9):1427–42. doi:https://doi.org/10.3390/jcm8091427
- Miller NJ, Sampson J, Candeias LP, Bramley PM, Rice-Evans CA. Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996;384(3):240–2. [https://doi.org/https://doi.org/10.1016/0014-5793(96)00323-7] doi:https://doi.org/10.1016/0014-5793(96)00323-7
- Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys. 1989;274(2):532–8. [https://doi.org/https://doi.org/10.1016/0003-9861(89)90467-0] doi:https://doi.org/10.1016/0003-9861(89)90467-0
- Chen J, Jiang W, Shao L, Zhong D, Wu Y, Cai J. Association between intake of antioxidants and pancreatic cancer risk: a meta-analysis. Int J Food Sci Nutr. 2016;67(7):744–53. doi:https://doi.org/10.1080/09637486.2016.1197892
- Huang X, Gao Y, Zhi X, Ta N, Jiang H, Zheng J. Association between vitamin A, retinol and carotenoid intake and pancreatic cancer risk: Evidence from epidemiologic studies. Sci Rep. 2016;6:38936. [doi:https://doi.org/10.1038/srep38936.
- Jeurnink SM, Ros MM, Leenders M, van Duijnhoven FJB, Siersema PD, Jansen EHJM, van Gils CH, Bakker MF, Overvad K, Roswall N, et al. Plasma carotenoids, vitamin C, retinol and tocopherols levels and pancreatic cancer risk within the European prospective investigation into cancer and nutrition: a nested case-control study: plasma micronutrients and pancreatic cancer risk. Int J Cancer. 2015;136(6):E665–E676. doi:https://doi.org/10.1002/ijc.29175
- Nkondjock A, Ghadirian P, Johnson KC, Krewski D, the Canadian Cancer Registries Epidemiology Research Group. Dietary intake of lycopene is associated with reduced pancreatic cancer risk. J Nutr. 2005;135(3):592–7. doi:https://doi.org/10.1093/jn/135.3.592
- Majima T, Tsutsumi M, Nishino H, Tsunoda T, Konishi Y. Inhibitory effects of beta-carotene, palm carotene, and green tea polyphenols on pancreatic carcinogenesis initiated by N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters. Pancreas. 1998;16:13–8. doi:https://doi.org/10.1097/00006676-199801000-00003
- Appel MJ, Roverts G, Woutersen RA. Inhibitory effects of micronutrients on pancreatic carcinogenesis in azaserine-treated rats. Carcinogenesis. 1991;12(11):2157–61. doi:https://doi.org/10.1093/carcin/12.11.2157
- Jeong Y, Lim JW, Kim H. Lycopene inhibits reactive oxygen species-mediated NF-κB signaling and induces apoptosis in pancreatic cancer cells. Nutrients. 2019;11(4):762–78. doi:https://doi.org/10.3390/nu11040762
- Seo JY, Masamune A, Shimosegawa T, Kim TH. Protective effect of lycopene on oxidative stress-induced cell death of pancreatic acinar cells. Ann N Y Acad Sci. 2009;1171:570–5. doi:https://doi.org/10.1111/j.1749-6632.2009.04712.x
- Rangarajan P, Subramaniam D, Paul S, Kwatra D, Palaniyandi K, Islam S, Harihar S, Ramalingam S, Gutheil W, Putty S, et al. Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells. Oncotarget. 2015;6(29):27661–73. doi:https://doi.org/10.18632/oncotarget.4871
- Mori K, Ooi T, Hiraoka M, Oka N, Hamada H, Tamura M, Kusumi T. Fucoxanthin and its metabolites in edible brown algae cultivated in deep seawater. Mar Drugs. 2004;2(2):63–72. doi:https://doi.org/10.3390/md202063
- Terasaki M, Kuramitsu Y, Kojoma M, Kim SY, Tanaka T, Maeda H, Miyashita K, Kawagoe C, Kohno S, Mutoh M. High fucoxanthin wakame (Undaria pinnatifida) prevents tumor microenvironment formation in an AOM/DSS mouse carcinogenic model. J Func Foods. 2020;64:103709. doi:https://doi.org/10.1016/j.jff.2019.103709
- Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, Nagao A. Carotenoids affect proliferation of human prostate cancer cells. J Nutr. 2001;131(12):3303–6. doi:https://doi.org/10.1093/jn/131.12.3303
- Hashimoto T, Ozaki Y, Mizuno M, Yoshida M, Nishitani Y, Azuma T, Komoto A, Maoka T, Tanino Y, Kanazawa K. Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of Kombu extract. Br J Nutr. 2012;107(11):1566–9. doi:https://doi.org/10.1017/S0007114511004879
- Yonekura L, Kobayashi M, Terasaki M, Nagao A. Keto-carotenoids are the major metabolites of dietary lutein and fucoxanthin in mouse tissues. J Nutr. 2010;140(10):1824–31. doi:https://doi.org/10.3945/jn.110.126466
- Nishino H, Murakoshi M, Tokuda H, Satomi Y. Cancer prevention by carotenoids. Arch Biochem Biophys. 2009;483(2):165–8. doi:https://doi.org/10.1016/j.abb.2008.09.011
- Hitoe S, Shimoda H. Seaweed fucoxanthin supplementation improves obesity parameters in mild obese Japanese subjects. FFHD. 2017;7(4):246–62. doi:https://doi.org/10.31989/ffhd.v7i4.333
- Mikami N, Hosokawa M, Miyashita K, Sohma H, Ito YM, Kokai Y. Reduction of HbA1c levels by fucoxanthin-enriched akamoku oil possibly involves the thrifty allele of uncoupling protein 1 (UCP1): a randomised controlled trial in normal-weight and obese Japanese adults. J Nutr Sci. 2017;6:e5. doi:https://doi.org/10.1017/jns.2017.1
- Jin X, Zhao T, Shi D, Ye MB, Yi Q. Protective role of fucoxanthin in diethylnitrosamine-induced hepatocarcinogenesis in experimental adult rats. Drug Dev Res. 2019;80(2):209–17. doi:https://doi.org/10.1002/ddr.21451
- Terasaki M, Ikuta M, Kojima H, Tanaka T, Maeda H, Miyashita K, Mutoh M. Dietary fucoxanthin induces anoikis in colorectal adenocarcinoma by suppressing integrin signaling in a murine colorectal cancer model. JCM. 2019;9(1):90–104. doi:https://doi.org/10.3390/jcm9010090
- Chen W, Zhang H, Liu Y. Anti-inflammatory and apoptotic signaling effect of fucoxanthin on benzo(a)pyrene-induced lung cancer in mice. J Environ Pathol Toxicol Oncol. 2019;38(3):239–51. doi:https://doi.org/10.1615/JEnvironPatholToxicolOncol.2019030301
- Tsuboi M, Etoh H, Kato K, Nakatugawa H, Kato H, Maejima Y, Matsumoto G, Mori H, Hosokawa M, Miyashita K, et al. Nitrocapsanthin and nitrofucoxanthin, respective products of capsanthin and fucoxanthin reaction with peroxynitrite. J Agric Food Chem. 2011;59(19):10572–8. doi:https://doi.org/10.1021/jf203493k
- Jin Y, Qiu S, Shao N, Zheng J. Fucoxanthin and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically promotes apoptosis of human cervical cancer cells by targeting PI3K/Akt/NF-κB signaling pathway. Med Sci Monit. 2018;24:11–8. doi:https://doi.org/10.12659/msm.905360
- Hosokawa M, Kudo M, Maeda H, Kohno H, Tanaka T, Miyashita K. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARgamma ligand, troglitazone, on colon cancer cells. Biochim Biophys Acta. 2004;1675(1–3):113–9. doi:https://doi.org/10.1016/j.bbagen.2004.08.012
- Terasaki M, Maeda H, Miyashita K, Mutoh M. Induction of anoikis in human colorectal cancer cells by fucoxanthinol. Nutr Cancer. 2017;69(7):1043–52. doi:https://doi.org/10.1080/01635581.2017.1339814
- Yu RX, Yu RT, Liu Z. Inhibition of two gastric cancer cell lines induced by fucoxanthin involves downregulation of Mcl-1 and STAT3. Hum Cell. 2018;31(1):50–63. doi:https://doi.org/10.1007/s13577-017-0188-4
- Liu Y, Zheng J, Zhang Y, Wang Z, Yang Y, Bai M, Dai Y. Fucoxanthin activates apoptosis via inhibition of PI3K/Akt/mTOR pathway and suppresses invasion and migration by restriction of p38-MMP-2/9 pathway in human glioblastoma cells. Neurochem Res. 2016;41(10):2728–51. doi:https://doi.org/10.1007/s11064-016-1989-7
- Kotake-Nara E, Terasaki M, Nagao A. Characterization of apoptosis induced by fucoxanthin in human promyelocytic leukemia cells. Biosci Biotechnol Biochem. 2005;69(1):224–7. doi:https://doi.org/10.1271/bbb.69.224
- Terasaki M, Mima M, Kudoh S, Endo T, Maeda H, Hamada J, Osada JK, Miyashita K, Mutoh M. Glycine and succinic acid are effective indicators of the suppression of epithelial-mesenchymal transition by fucoxanthinol in colorectal cancer stem-like cells. Oncol Rep. 2018;40(1):414–24. doi:https://doi.org/10.3892/or.2018.6398
- Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–50. doi:https://doi.org/10.1073/pnas.0506580102
- Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstråle M, Laurila E, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–73. doi:https://doi.org/10.1038/ng1180
- Dai M, Al-Odaini AA, Fils-Aimé N, Villatoro MA, Guo J, Arakelian A, Rabbani SA, Ali S, Lebrun J. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion. Breast Cancer Res. 2013;15(3):R49. doi:https://doi.org/10.1186/bcr3441
- Pramanik KC, Fofaria NM, Gupta P, Ranjan A, Kim SH, Srivastava SK. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3. Oncotarget. 2015;6(13):11561–74. doi:https://doi.org/10.18632/oncotarget.3427
- Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398(6726):422–6. doi:https://doi.org/10.1038/18884
- Chen ZY, Cai L, Bie P, Wang SG, Jiang Y, Dong JH, Li XW. Roles of Fyn in pancreatic cancer metastasis. J Gastroenterol Hepatol. 2010;25(2):293–301. doi:https://doi.org/10.1111/j.1440-1746.2009.06021.x
- Jiang P, Li Z, Tian F, Li X, Yang J. Fyn/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin β1. Int J Oncol. 2017;51(1):169–83. doi:https://doi.org/10.3892/ijo.2017.4018
- Baillat G, Siret C, Delamarre E, Luis J. Early adhesion induces interaction of FAK and Fyn in lipid domains and activates raft-dependent Akt signaling in SW480 colon cancer cells. Biochim Biophys Acta. 2008;1783(12):2323–31. doi:https://doi.org/10.1016/j.bbamcr.2008.08.008
- Yadav V, Denning MF. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration. Mol Carcinog. 2011;50(5):346–52. doi:https://doi.org/10.1002/mc.20716
- De Franceschi N, Hamidi H, Alanko J, Sahgal P, Ivaska J. Integrin traffic - the update. J Cell Sci. 2015;128(5):839–52. doi:https://doi.org/10.1242/jcs.161653
- Zhou G, Chiu D, Qin D, Niu L, Cai J, He L, Tan D, Xu K. Expression of CD44v6 and integrin-β1 for the prognosis evaluation of pancreatic cancer patients after cryosurgery. Diagn Pathol. 2013;8(1):146. doi:https://doi.org/10.1186/1746-1596-8-146
- Zhao J, Guan JL. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev. 2009;28(1–2):35–49. doi:https://doi.org/10.1007/s10555-008-9165-4
- Song M, Bode AM, Dong Z, Lee MH. AKT as a therapeutic target for cancer. Cancer Res. 2019;79(6):1019–31. doi:https://doi.org/10.1158/0008-5472.CAN-18-2738
- Polvani S, Tarocchi M, Tempesti S, Bencini L, Galli A. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer. World J Gastroenterol. 2016;22(8):2441–59. doi:https://doi.org/10.3748/wjg.v22.i8.2441
- Fujita M, Sasada M, Iyoda T, Fukai F. Involvement of integrin-activating peptides derived from Tenascin-C in cancer aggression and new anticancer strategy using the fibronectin-derived integrin-inactivating peptide. Molecules. 2020;25(14):3239. doi:https://doi.org/10.3390/molecules25143239
- Yang D, Hu Z, Xu J, Tang Y, Wang Y, Cai Q, Zhu Z. MiR-760 enhances sensitivity of pancreatic cancer cells to gemcitabine through modulating integrin β1. Biosci Rep. 2019;39. 39BSR20192358. [ doi:https://doi.org/10.1042/BSR20192358
- Zhao Y, Miao G, Li Y, Isaji T, Gu J, Li J, Qi R. MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1 [corrected]. PLoS One. 2014;9(2):e87938. doi:https://doi.org/10.1371/journal.pone.0087938
- Li E, Wei B, Wang X, Kang R. METTL3 enhances cell adhesion through stabilizing integrin β1 mRNA via an m6A-HuR-dependent mechanism in prostatic carcinoma. Am J Cancer Res. 2020;10(3):1012–25.
- Liu Z, Wang Y, Dou C, Sun L, Li Q, Wang L, Xu Q, Yang W, Liu Q, Tu K. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2018;37(1):49. doi:https://doi.org/10.1186/s13046-018-0717-3
- Gu JJ, Zhang JH, Chen HJ, Wang SS. MicroRNA-130b promotes cell proliferation and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma cells. Int J Mol Med. 2016;37(6):1587–93. doi:https://doi.org/10.3892/ijmm.2016.2580
- Motawi TK, Shaker OG, Ismail MF, Sayed NH. Peroxisome proliferator-activated receptor gamma in obesity and colorectal cancer: the role of epigenetics. Sci Rep. 2017;7(1):10714. doi:https://doi.org/10.1038/s41598-017-11180-6
- Al-Wadei HAN, Majidi M, Tsao MS, Schuller HM. Low concentrations of beta-carotene stimulate the proliferation of human pancreatic duct epithelial cells in a PKA-dependent Manner. Cancer Genomics Proteomics. 2007;4: 35–42.
- García-Regalado A, Vargas M, García-Carrancá A, Aréchaga-Ocampo E, González-De l. R C. Activation of Akt pathway by transcription-independent mechanisms of retinoic acid promotes survival and invasion in lung cancer cells. Mol Cancer. 2013;12:44. doi:https://doi.org/10.1186/1476-4598-12-44
- Kweon MH, Adhami VM, Lee JS, Mukhtar H. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J Biol Chem. 2006;281(44):33761–72. doi:https://doi.org/10.1074/jbc.M604748200